关注
Jillian Richmond
Jillian Richmond
University of Massachusetts
在 umassmed.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
M Rashighi, P Agarwal, JM Richmond, TH Harris, K Dresser, MW Su, ...
Science translational medicine 6 (223), 223ra23-223ra23, 2014
4692014
CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation
JR Groom, J Richmond, TT Murooka, EW Sorensen, JH Sung, K Bankert, ...
Immunity 37 (6), 1091-1103, 2012
4502012
Innate immune mechanisms in vitiligo: danger from within
JM Richmond, ML Frisoli, JE Harris
Current opinion in immunology 25 (6), 676-682, 2013
2242013
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
JM Richmond, JP Strassner, L Zapata Jr, M Garg, RL Riding, MA Refat, ...
Science translational medicine 10 (450), eaam7710, 2018
1992018
Immunology and skin in health and disease
JM Richmond, JE Harris
Cold Spring Harbor perspectives in medicine 4 (12), a015339, 2014
1902014
Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease
JM Richmond, DS Bangari, KI Essien, SD Currimbhoy, JR Groom, ...
Journal of Investigative Dermatology 137 (2), 350-358, 2017
1672017
Regulation of cellular processes by interleukin‐16 in homeostasis and cancer
J Richmond, M Tuzova, W Cruikshank, D Center
Journal of cellular physiology 229 (2), 139-147, 2014
1572014
Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo
JM Richmond, JP Strassner, M Rashighi, P Agarwal, M Garg, KI Essien, ...
Journal of Investigative Dermatology 139 (4), 769-778, 2019
1132019
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
P Agarwal, M Rashighi, KI Essien, JM Richmond, L Randall, ...
Journal of Investigative Dermatology 135 (4), 1080-1088, 2015
1052015
Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity
JP Strassner, M Rashighi, MA Refat, JM Richmond, JE Harris
Journal of the American Academy of Dermatology 76 (5), 847-855. e5, 2017
1012017
CXCR3 depleting antibodies prevent and reverse vitiligo in mice
JM Richmond, E Masterjohn, R Chu, J Tedstone, ME Youd, JE Harris
The Journal of investigative dermatology 137 (4), 982-985, 2017
752017
Resident memory T cells in autoimmune skin diseases
GE Ryan, JE Harris, JM Richmond
Frontiers in immunology 12, 652191, 2021
732021
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
SG Vanderweil, S Amano, WC Ko, JM Richmond, M Kelley, MM Senna, ...
Journal of the American Academy of Dermatology 76 (1), 150-151. e3, 2017
472017
Jak inhibition prevents bleomycin-induced fibrosis in mice and is effective in patients with morphea
W Damsky, D Patel, CJ Garelli, M Garg, A Wang, K Dresser, A Deng, ...
The Journal of investigative dermatology 140 (7), 1446-1449. e4, 2020
392020
Mouse model for human vitiligo
RL Riding, JM Richmond, JE Harris
Current protocols in immunology 124 (1), e63, 2019
382019
Current insights in cutaneous lupus erythematosus immunopathogenesis
CJ Garelli, MA Refat, PP Nanaware, ZG Ramirez-Ortiz, M Rashighi, ...
Frontiers in Immunology 11, 1353, 2020
342020
T‐cell positioning by chemokines in autoimmune skin diseases
JM Richmond, JP Strassner, KI Essien, JE Harris
Immunological reviews 289 (1), 186-204, 2019
342019
Interleukin-16 as a marker of Sezary syndrome onset and stage
J Richmond, M Tuzova, A Parks, N Adams, E Martin, M Tawa, L Morrison, ...
Journal of clinical immunology 31, 39-50, 2011
342011
Immunopathogenesis of alopecia areata
JM Richmond
Current Research in Immunology 2, 7-11, 2021
322021
Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells
V Azzolino, L Zapata Jr, M Garg, M Gjoni, RL Riding, JP Strassner, ...
The Journal of investigative dermatology 141 (1), 182, 2021
322021
系统目前无法执行此操作,请稍后再试。
文章 1–20